J A Garcia Urbina
Universidad Aut�³noma de Baja California Sur (UABCS), Mexico
Posters-Accepted Abstracts: J Cancer Sci Ther
Cancer in early phase without adverse side effects is the expected target in the world. The cancer originates in glandular system produces various organ dysfunctions, and in metastases loss of life in a short time, public health problem of great social and economic importance. Carbohydrate -C40H56- Hydro-soluble Carotene (HC) identified as lycopene food used in this protocol is safe and complete solubility in water diffuses into the tissues where it is more benign and remarkable effect early tumor suppression than any other treatment except in stomach cancer, suppresses associated neuropathy, without adverse side effects, and glandular system activates. HC administered in the diet at doses of 70�±2, 140�±4, 200�±4 and 270�±2mg, depending on the stage I, II, III and IV cancer, every 8 hours according to protocol and algorithm: T = D / V. Where T is the time in days of treatment the tumor, D is the maximum distance in mm from one point to another tumor, V is the average velocity (1mm/day) referral to tumor suppression. If the tumor size is 80x60x40 mm (the maximum distance D from one point to another of the tumor is 80 mm), time to tumor treatment T will be 80 days: T = 80 mm /1 mm /day = 80 days. From this it follows that T=D. In conclusion, the repeated finding referral to prompt suppression of the tumor with HC makes me think, cancer and other degenerative cellular alterations of glandular origin result from ancestral carotene deficiency in the diet, by suppression under sufficient dosage.
Email: biotiquin@gmail.com
Cancer Science & Therapy received 5332 citations as per Google Scholar report